Moscow provides more evidence of US biolabs in Ukraine
Russia’s Defense Ministry on Monday laid out more evidence that US-funded laboratories were working in Ukraine. Documents and materials recovered by Russian troops showed that Western pharmaceutical companies operating in territory under Kiev’s control conducted HIV/AIDS research on Ukrainian military personnel.
The commander of Russia’s Nuclear, Biological and Chemical Defense Forces, Lieutenant General Igor Kirillov, presented Ukrainian-language documents referring to HIV infection studies that began in 2019. The list of targeted groups shows service members alongside prisoners, drug addicts and other “patients at high risk of infection.”
According to Kirillov, the Russian military has recovered more than 20,000 documents and other materials related to the biological programs in Ukraine, while interviewing eyewitnesses and participants. The evidence “confirms the focus of the Pentagon on creating biological weapons components and testing them on the population of Ukraine and other states along [Russia’s] borders,” the general told reporters.
Based on documents originating with the Pentagon’s Defense Threat Reduction Agency (DTRA), the Russian military identified eight more individuals involved in the US-funded research in Ukraine. Among the names Kirillov singled out was Karen Saylors of Labyrinth Global Health, previously of Metabiota, a company linked to US President Joe Biden’s son Hunter.
The latest trove of documents, belonging to the company Pharmbiotest, was unearthed in Lisichansk in the Lugansk People’s Republic (LPR) early in January, Kirillov noted.
“Clinical samples and patient records with their personal data were buried, and not cremated or destroyed in a proper fashion. This suggests that the destruction of this evidence was carried out in extreme haste,” the lieutenant general said.
In October 2022, Russia filed an official complaint over alleged US-backed biological activities in Ukraine and requested a UN probe into the matter. The UN Security Council rejected Moscow’s proposal after the US, UK, and France voted against it. The US opposition “once again confirms that Washington has something to hide, and that ensuring the transparency of biological research is contrary to US interests,” Kirillov said.
As evidence of the widespread threat posed by the Pentagon’s biological research conducted beyond America’s borders, Kirillov referred to the previously mentioned US involvement in coronavirus studies, including by funding the nonprofit EcoHealth Alliance that contracted with the laboratory in Wuhan, China.
Kirillov also brought up the 1977 outbreak of Rift Valley Fever in Egypt, near a biological laboratory run by the US Navy. The disease previously known only south of the Sahara made a surprise appearance in Cairo a few months after the lab employees were vaccinated against it, the general said. Moreover, the Cairo strain was “highly pathogenic” compared to the disease’s normal flu-like symptoms, suggesting the involvement of gain-of-function experiments.
